Status:
COMPLETED
Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)
Lead Sponsor:
New York State Psychiatric Institute
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Obsessive-compulsive disorder (OCD) is a common psychiatric illness that affects up to 2-3% of the population. People with OCD experience anxiety-provoking, intrusive thoughts, known as obsessions, an...
Eligibility Criteria
Inclusion
- Primary DSM-IV Diagnosis of OCD
- Currently on a stable and adequate dose of SRI (or history of prior SRI or CBT treatment meeting criteria for adequate trial)
- Patients not currently receiving an SRI or CBT will be included if they have undergone a prior SRI or CBT trial and they report no interest in pursuing another DRI or CBT trial at this time. Patients who have been on SRIs in the past must be free of SRIs for at least 6 weeks prior to participation
- Y-BOCS score of greater or equal to 16
- Physically health and females must be using effective contraception
- Sufficient severity of symptoms to warrant additional augmentation treatment
- Able to provide consent
Exclusion
- Ongoing treatment with other antibiotics and/or Accutane. Patients with lupus erythematosus
- Patients planning to start CBT during the study period or those who have begun CBT within the past 8 weeks
- Presence of psychotic symptoms or lifetime history of schizophrenia, bipolar disorder or other psychotic disorder
- Current major depressive disorder (patients must be free of the disorder for 3 months prior to enrollment). HAM-D must be \<18.
- Judged clinically to be at risk of suicide (suicidal ideation, severe depression or other factors
- Current eating disorder
- Severe renal insufficiency
- Documented history of hypersensitivity or intolerance to tetracycline antibiotics
- Concomitant use of anti-coagulant drugs, antacids, iron, calcium, magnesium, aluminum, zinc sales. Note:Concomitant psychotropic medications such as antipsychotics and benzodiazepines will be permitted as long as they have been stable for at least 4 weeks and remain stable during the course of the study.
- Current ETOH/drug abuse or dependence disorder of dependency in the past 3 months
- Female patients who are either pregnant or nursing
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00728923
Start Date
August 1 2008
End Date
July 1 2011
Last Update
April 2 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032